ArticleAmerican journal of translational research2024
The use of MFAP2 for diagnosis, prognosis and immunotherapy of triple-negative breast cancer.
Jingjing Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it